Day: June 28, 2021

MENLO PARK, Calif., June 28, 2021 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced today that it has joined the Russell Microcap® Index, effective after the U.S. market opens today, June 28. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Dr. James Woody, 180 Life Sciences Chief Executive Officer, stated, “The Russell indexes are widely used investment benchmarks for index funds and...

LIMA, Peru, June 28, 2021 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera” or the “Company”) (BVL:MIRL) (CSE:MIRL), is pleased to announce the results of an updated Mineral Resource Estimate (“2021 MRE”) for its Corihuarmi Gold Mine (“Corihuarmi”) located in central Peru. The 2021 MRE, which was compiled and completed by consulting firm Mining Plus in accordance with the requirements of National Instrument 43-101 (“NI 43-101”), confirms the existence of sufficient resources to extend the life of mine (“LOM”) at Corihuarmi to August 2024, including measured and indicated resources totalling 13.8 million tonnes at an average grade of 0.21 grams per tonne (“g/t”). Diego Benavides, CEO of Minera IRL Limited, stated: “This is great news for us, as Corihuarmi – which, by the way, translates from Quechua into English as ‘the Golden Woman’...

CORAL GABLES, Fla., June 28, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it has entered into an exclusive license and supply agreement with DyDo Pharma, Inc. (“DyDo Pharma”) for the development and commercialization of Firdapse® (amifampridine) Tablets 10 mg in Japan for the treatment of Lambert-Eaton myasthenic syndrome (“LEMS”). LEMS is a rare autoimmune neuromuscular disorder characterized by debilitating and progressive muscle weakness and fatigue. Under the terms of the agreement, DyDo Pharma will have joint rights to develop Firdapse® (amifampridine phosphate), and exclusive...

– Expansion of management team with proven leader in cardiovascular disease supports advancement of CLEAR Outcomes trial and ESPERION therapeutic pipeline – ANN ARBOR, Mich., June 28, 2021 (GLOBE NEWSWIRE) — ESPERION (NASDAQ: ESPR), today announced the appointment of JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer, effective immediately. She will serve as a member of the executive team and report to Sheldon Koenig, President and Chief Executive Officer. Dr. Foody brings more than 20 years of experience in academic and preventive cardiology to ESPERION. “Dr. Foody is a global expert with extensive clinical and medical experience in preventive cardiology, global medical development and medical affairs, which adds greatly to the depth of our management team,” said Sheldon Koenig, President and Chief Executive Officer...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — Loncor Gold Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce a non-brokered private placement of up to 7,000,000 units of the Company (the “Units“) at a price of Cdn$0.70 per Unit for gross proceeds of up to Cdn$4,900,000 (the “Financing“). Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant“) of the Company, with each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price of Cdn$0.95 for a period of 12...

Seasoned Executive Focused on Global Cloud Business Growth at Amazon and Microsoft Joins Inovalon BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon’s Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company’s multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total customer experience, and industry leadership. “Eron...

BEVERLY, Mass., June 28, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG), (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has retained LaVoieHealthScience (LHS) as its investor and public relations (IR and PR) agency of record. LHS will work side-by-side with LexaGene’s senior management, marketing, and financial teams to implement a comprehensive suite of IR and PR services and counsel to help the Company gain visibility among the investment community, as it charts a course toward a potential up-listing to the Nasdaq Stock Market in the United States. LHS is a strategic, integrated communications firm with a keen focus on helping life science and medical technology companies solve complex communications challenges....